Form 8-K - Current report:
SEC Accession No. 0001193125-25-056708
Filing Date
2025-03-18
Accepted
2025-03-18 16:38:49
Documents
18
Period of Report
2025-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d839636d8k.htm   iXBRL 8-K 31759
2 EX-3.1 d839636dex31.htm EX-3.1 31544
3 EX-3.2 d839636dex32.htm EX-3.2 171646
4 EX-99.1 d839636dex991.htm EX-99.1 73893
9 GRAPHIC g839636g0319004049663.jpg GRAPHIC 2854
  Complete submission text file 0001193125-25-056708.txt   531871

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA whwk-20250318.xsd EX-101.SCH 3209
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE whwk-20250318_def.xml EX-101.DEF 14210
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE whwk-20250318_lab.xml EX-101.LAB 23439
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE whwk-20250318_pre.xml EX-101.PRE 15086
21 EXTRACTED XBRL INSTANCE DOCUMENT d839636d8k_htm.xml XML 5816
Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 25749020
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)